Machine signal
Active cluster buy — 10 distinct insiders, $159M, window ends Aug 7, 2026.
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Braveheart Bio, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Figures computed from official regulatory filings — .
Business description unavailable in our sources.
SEC company identity · Nov 2, 2026
Purchases and sales · full history
13 buysbar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| AH Bio Fund IV, L.P. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Chimovits Ereztrack record | Other | n/a (No price was disclosed in the filing) | SEC | ||
| AH Bio Fund IV, L.P. | Other | n/a (No price was disclosed in the filing) | SEC | ||
| AH Bio Fund IV, L.P. | Buy | $19.8M | conv 54ClusterFirst in 12mo | SEC | |
| ORBIMED ADVISORS LLCtrack record | Other | n/a (No price was disclosed in the filing) | SEC | ||
| ORBIMED ADVISORS LLCtrack record | Buy | $4.9M | conv 44Cluster | SEC | |
| Chimovits Ereztrack record | Buy | $4.9M | conv 58ClusterFirst in 12mo | SEC | |
| Chimovits Ereztrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| ORBIMED ADVISORS LLCtrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| ORBIMED ADVISORS LLCtrack record | Buy | $30M | conv 60ClusterUnusual size | SEC | |
| Chimovits Ereztrack record | Buy | $30M | conv 65ClusterUnusual size+1 | SEC | |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Other | n/a (No price was disclosed in the filing) | SEC | ||
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Anderson Michele A. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Murdoch Travis | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | Buy | $34.6M | conv 57ClusterFirst in 12mo | SEC | |
| Anderson Michele A. | Buy | $20K | conv 58ClusterFirst in 12mo | SEC | |
| Lohoff Tim | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Chimovits Ereztrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Malek David I | Buy | $75K | conv 54ClusterFirst in 12mo | SEC | |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | Buy | $30.2M | conv 57ClusterFirst in 12mo | SEC | |
| Malek David I | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |